scholarly journals Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma

Cancer ◽  
2008 ◽  
Vol 112 (9) ◽  
pp. 2038-2045 ◽  
Author(s):  
Marc C. Chamberlain ◽  
Denice D. Wei-Tsao ◽  
Deborah T. Blumenthal ◽  
Michael J. Glantz
Cancer ◽  
2006 ◽  
Vol 106 (1) ◽  
pp. 172-179 ◽  
Author(s):  
Marc C. Chamberlain ◽  
Denice D. Tsao-Wei ◽  
Susan Groshen

2015 ◽  
Vol 24 (3) ◽  
pp. 379-382
Author(s):  
Tadahisa Inoue ◽  
Hitoshi Sano ◽  
Takashi Mizushima ◽  
Hirotada Nishie ◽  
Hiroyasu Iwasaki ◽  
...  

We present the case of a Japanese man in his 60s with duodenal neuroendocrine carcinoma with distant metastases. Chemotherapy with irinotecan plus cisplatin was initiated as a first-line regimen. However, disease progression was observed after only two cycles. Therefore, amrubicin was administered as a second-line chemotherapy. The patient showed a long-term effect of amrubicin therapy, and the best response was a partial response after seven cycles. For duodenal neuroendocrine carcinoma, amrubicin therapy can be considered an effective treatment option as salvage chemotherapy.


2013 ◽  
Vol 9 (1) ◽  
pp. 1-7
Author(s):  
Alessandra Romano ◽  
Giuseppina Uccello ◽  
Paolo Spina ◽  
Rosario Cunsolo ◽  
Calogero Vetro ◽  
...  

2021 ◽  
Author(s):  
Adham A. Aljariri ◽  
Ahmed Shaikh ◽  
Abdulqadir J. Nashwan ◽  
Mahir A. Petkar ◽  
Shanmugam Ganesan

Sign in / Sign up

Export Citation Format

Share Document